Anti-SMYD4 Antibody

A polyclonal primary antibody from Antibodies.com targets SMYD4 (SET and MYND domain-containing protein 4), a chromatin-associated lysine methyltransferase involved in transcriptional regulation. Raised in rabbit and supplied as 100 µl of unconjugated antiserum, the reagent is validated for western blot and immunofluorescence workflows on human samples.

SMYD4 has been studied as a candidate tumor suppressor in breast cancer research, where reduced expression has been linked to disease progression, and as a regulator of skeletal muscle differentiation and cardiac morphogenesis. Investigators use this antibody to probe endogenous SMYD4 levels in chromatin biology, gene-expression control, and developmental studies. The unconjugated format allows flexible pairing with fluorophore- or enzyme-labeled secondary reagents, supporting both immunofluorescence detection and western blot imaging of the target protein.